The Host-Pathogen interaction of human cyclophilin A and HIV-1 Vpr requires specific N-terminal and novel C-terminal domains

BACKGROUND: Cyclophilin A (CypA) represents a potential key molecule in future antiretroviral therapy since inhibition of CypA suppresses human immunodeficiency virus type 1 (HIV-1) replication. CypA interacts with the virus proteins Capsid (CA) and Vpr, however, the mechanism through which CypA inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Solbak, Sara MØ, Wray, Victor, Horvli, Ole, Raae, Arnt J, Flydal, Marte I, Henklein, Petra, Henklein, Peter, Nimtz, Manfred, Schubert, Ulrich, Fossen, Torgils
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269379/
https://www.ncbi.nlm.nih.gov/pubmed/22185200
http://dx.doi.org/10.1186/1472-6807-11-49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269379/
https://www.ncbi.nlm.nih.gov/pubmed/22185200
http://dx.doi.org/10.1186/1472-6807-11-49

Ejemplares similares